Typically, HMGA2 shows greater expression in sarcomas, brain and central nervous system tumors, as well as in cancers of the esophagus, head and neck, lung, melanoma, ovary, and pancreas, relative to their normal tissue counterparts. This evidence concerns the gene HMGA2 and cancer.